Renewal of Bachem’s import license to India

October 16, 2013

The Drug Controller General of India renewed Bachem’s license for importing generic active pharmaceutical ingredients (API) to India in August 2013.

This renewal enables us to continue marketing the peptide drug substances calcitonin, goserelin, leuprolide, and somatostatin in India during the upcoming three years. By obtaining the permit, Bachem has additionally safeguarded its API imports to India in terms of compliance.


At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.

View all jobs

Click here >>

Contact us